+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Chemotherapy of nonseminomatous testicular tumors. The results of a pilot study with reduced cis-platin dosage

Chemotherapy of nonseminomatous testicular tumors. The results of a pilot study with reduced cis-platin dosage

Onkologie 6(3): 144-147

23 patients with non-seminomatous germ cell tumors of the testis were treated with Cis-Platinum 50 mg/m2 body surface on day 1, Vinblastine 0,4 mg/kg body weight in two doses on days 1 and 2, and Bleomycin 30 mg daily as continuous infusion (days 2-5). 7 patients were treated adjuvant after retroperitoneal lymphadenectomy. One of these had a relapse, he again received the same therapy and now has a complete remission. All other adjuvant treated patients are free of tumor. Of the 16 patients with large retroperitoneal and/or lung metastases, 10 (62%) had a complete remission, 2 of them after resection of persistent metastases after chemotherapy. 4 of the 10 patients with complete remission relapsed. In two patients with relapse a new complete remission could be established by the same chemotherapy. The remission rates achieved with this therapy with a relatively low dose of Cis-Platinum are similar to those obtained with higher doses of this agent. It is possible that there are more relapses, but these respond well to further treatment. Thus, the survival times of the patients treated with this protocol are similar to those reported in the literature. It is concluded that this regimen is an effective treatment in non seminomatous germ cell tumors.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 042522832

Download citation: RISBibTeXText

PMID: 6193474

Related references

The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group. Seminars in Oncology 25(2 Suppl 4): 24-32; Discussion 45-8, 1998

Retroperitoneal lymphadenectomy (RPLA) or primary cisplatin (CCDP) - based chemotherapy (CHT) in clinical stage (CS) B1/B2 nonseminomatous testicular tumors (NSTT): long term results of the prospective non-randomized study. 2007

Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin-vinblastine-bleomycin chemotherapy. Journal of Surgical Oncology 38(4): 227-232, 1988

Results of Adjuvant Surgery in Patients with Stage III and IV Nonseminomatous Testicular Tumors after Cisplatin-Vinblastine-Bleomycin Chemotherapy. Journal of Urology 141(6): 1498-1499, 1989

Primary chemotherapy for clinical stage II nonseminomatous germ cell testicular tumors: Selection criteria and long-term results. Mayo Clinic Proceedings 70(9): 821-828, 1995

Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. Journal of Clinical Oncology 21(8): 1505-1512, 2003

Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. Journal of Urology 161(4): 1148-1152, 1999

The chemotherapy of nonseminomatous testicular tumors. Urologiia i Nefrologiia .(2): 26-29, 1996

Chemotherapy of nonseminomatous testicular tumors. Urologiya i Nefrologiya 0(2): 26-29, 1996

Results of treatment of randomized study in 71 patients with metastatic nonseminomatous testicular tumors stage iv. Seeber, S Et Al (Ed ) Beitraege Zur Onkologie, Band 3 Cisplatin: Derzeitiger Stand Und Neue Entwicklungen in Der Chemotherapie Maligner Neoplasien (Contributions to Oncology, Vol 3 Cisplatin (Cis-Diamminedichloroplatinum (Ii)): Present Status Of And New Developments in The Chemotherapy Of Malignant Neoplasms; Meeting, Frankfurt, West Germany, Nov 16, 1979) Vii+176p S Karger: Basel, Switzerland; New York, N Y , Usa Illus P90-102, 1980

Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group. Journal of Clinical Oncology 26(18): 2966-2972, 2008

Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group. Journal of Clinical Oncology 19(10): 2647-2657, 2001

The influence of chemotherapy on regional metastases in nonseminomatous testicular tumors. Voprosy Onkologii (St Petersburg) 34(10): 1219-1224, 1988

Gonadal function after surgery and chemotherapy in men with stage II and III nonseminomatous testicular tumors. Journal of Clinical Oncology 5(4): 651-656, 1987

Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors. Cancer 58(7): 1418-1421, 1986